Related references
Note: Only part of the references are listed.Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia
Michael O. Falster et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education
Shin J. Liau et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)
Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial
Manuel R. Blum et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Association between polypharmacy and health-related quality of life among US adults with cardiometabolic risk factors
Ami Vyas et al.
QUALITY OF LIFE RESEARCH (2020)
Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: a population-level analysis
Ami Vyas et al.
QUALITY OF LIFE RESEARCH (2020)
Polypharmacy is associated with multiple health-related outcomes in Mexican community-dwelling older adults
Aaron Salinas-Rodriguez et al.
SALUD PUBLICA DE MEXICO (2020)
Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness
Yael Schenker et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital
Henok Getachew Tegegn et al.
PLOS ONE (2019)
Polypharmacy among older Australians, 2006-2017: a population-based study
Amy T. Page et al.
MEDICAL JOURNAL OF AUSTRALIA (2019)
Developing a measure of polypharmacy appropriateness in primary care: systematic review and expert consensus study
Jenni Burt et al.
BMC MEDICINE (2018)
Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus
Edwin C. K. Tan et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2018)
Effects of a population-based, person-centred and integrated care service on health, wellbeing and self-management of community-living older adults: A randomised controlled trial on Embrace
Sophie L. W. Spoorenberg et al.
PLOS ONE (2018)
The prevalence and determinants of polypharmacy at age 69: a British birth cohort study
Mark James Rawle et al.
BMC GERIATRICS (2018)
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Lucas Morin et al.
CLINICAL EPIDEMIOLOGY (2018)
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Jonas W. Wastesson et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL
Lili Wang et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Health-related quality of life and associated factors in functionally independent older people
Monica Machon et al.
BMC GERIATRICS (2017)
What is polypharmacy? A systematic review of definitions
Nashwa Masnoon et al.
BMC GERIATRICS (2017)
Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy
Alonso Montiel-Luque et al.
PLOS ONE (2017)
Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study
Samanta Lalic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011
Dima M. Qato et al.
JAMA INTERNAL MEDICINE (2016)
Moving From Disease-Centered to Patient Goals-Directed Care for Patients WithMultiple Chronic Conditions Patient Value-Based Care
Mary E. Tinetti et al.
JAMA CARDIOLOGY (2016)
Quality of life (QOL) of the community-dwelling elderly and associated factors: A population-based study in urban areas of China
Wei Sun et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2015)
Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988-2010
Christina J. Charlesworth et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2015)
Health-related quality of life and activities of daily living in 85-year-olds in Sweden
Lena B. Andersson et al.
HEALTH & SOCIAL CARE IN THE COMMUNITY (2014)
Benchmarks for Interpretation of Score Differences on the SF-36 Health Survey for Patients with Diabetes
Jakob B. Bjorner et al.
VALUE IN HEALTH (2013)
Health-related Quality of Life: Expanding a Conceptual Framework to Include Older Adults Who Receive Long-term Services and Supports
Cynthia Zubritsky et al.
GERONTOLOGIST (2013)
Health status of the advanced elderly in six european countries: results from a representative survey using EQ-5D and SF-12
Hans-Helmut Koenig et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2010)
The Effects of Polypharmacy in Older Adults
S. N. Hilmer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
National surveillance of emergency department visits for outpatient adverse drug events
Daniel S. Budnitz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The validity of the SF-36 in an Australian National Household Survey: demonstrating the applicability of the Household Income and Labour Dynamics in Australia (HILDA) Survey to examination of health inequalities
P Butterworth et al.
BMC PUBLIC HEALTH (2004)
Share Paper
